Trial Profile
Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of Depigoid Grass Mix as a rush immunotherapy in patients with allergic rhinitis using an environmental exposure unit.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2011
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors LETI Pharma GmbH
- 08 Jul 2011 New trial record